 |
Recombinant methionyl brain-derived neurotrophic factor |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 1994-11-28 00:00:00 |
| Sponsor | Amgen, Inc.;One Amgen Center Dr., M/S: 17-2-B;Thousand Oaks, California, 91320 |
